In the accompanying paper (1) in situ hybridization of globin DNA copy (cDNA) to fetal liver was used to elucidate the process of globin messenger RNA (mRNA) formation in erythroid precursor cells. The essential conclusions were also confirmed by conventional hybridization studies. In the present paper, the same dual approach is applied to a different experimental system in which hemoglobin synthesis in Friend virus-transformed mouse cells is induced by treatment with dimethylsulfoxide (DMSO) (2). The results obtained by in situ and conventional hybridization agree in showing that there is a minimum period of treatment with DMSO required in order that globin mRNA and hemoglobin may accumulate.
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M A T E R I A L S AND METHODS

Cell Culture
Friend cells (clone 707) and lymphoma cells (L 5178Y) were grown in Ham's FI2 medium (Flow Laboratories, Irvine, Scotland), supplemented with minimal essential medium amino acids, penicillin (60 U/ml), and 10-15% horse serum and buffered with HEPES or bicarbonate. LS cells were grown in Eagle's minimal essential medium plus 5% calf serum.
All other methods are fully described in the accompanying paper (1).
RESULTS
Formation o f Hemoglobin
Friend cells normally grow from about 10 ~ cells/ml to 106 cells/ml with a doubling time of about 12 h. Friend cells grow in !.5% DMSO at about the same rate as untreated cells for about 3 days (six to seven generations); then cell division ceases and cells begin to accumulate hemoglobin, so that the percentage of hemoglobinized cells increases rapidly after the 3rd day of exposure to DMSO (Table 1) Table Ill Cells were inoculated from exponentially growing cultures at 105 cells/ml, and DMSO was added to a final concentration of 1.5%. (3, 4) or by the ability to direct globin synthesis in oocytes (5):
E f f e c t o f B r o m o d e o x y u r i d i n e
Bromodeoxyuridine (BUdR) prevents the formation of hemoglobinized cells in cultures of Friend cells treated with DMSO, provided that it is added before addition of DMSO (Table IV) . Similar results have been reported recently by other workers (6, 4) . Estimation of globin mRNA levels by in situ hybridization shows that this reduction in hemoglobin formation is due to greatly reduced levels of globin mRNA in cells treated with DMSO and BUdR as compared with DMSO alone (Table IV) . Similar conclusions concerning the effect of BUdR have been reported recently by Friend and coworkers, estimating the levels of globin mRNA by titration with globin cDNA (4).
DISCUSSION
The results presented in this paper show that Friend cells begin to accumulate hemoglobin during culture in DMSO: the proportion of hemoglobinized Friend cells increases sharply after 2 3 days in DMSO, reaching a maximum of about 85% after culture in DMSO for 5-6 days. Paul and Hickey (7) have shown by cloning experiments that the proportion of Friend cells (15%) which do not become hemoglobinized after treatment with DMSO does not represent a noninducible population of cells. The reason why certain cells in the population fail to respond to DMSO is not yet clear.
It is not necessarily valid to interpret the sudden increase in hemoglobinized cells (as detected by benzidine staining) to mean that hemoglobin synthesis is initiated 2-3 days after treatment of Friend cells with DMSO. However, the experi- 
TABLE IV
Effect of B UdR on Hemoglobin and Globin mR NA Formation in Friend Cells
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